Testing a new mRNA vaccine for moderate to severe acne
Part of Skin clinical trials.
This study tests an experimental mRNA vaccine designed to help the immune system fight acne-causing bacteria. It's for adults with moderate or severe facial acne who are otherwise healthy, and it may offer a new way to treat acne beyond typical creams or pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy, with no serious medical conditions
- You have moderate or severe facial acne (grade 3 or 4 on a doctor's scale)
- You have at least 25 blackheads/whiteheads and 20 red pimples/pustules, and 2 or fewer deep, painful cysts
- You have not used certain acne treatments recently (your doctor will check the washout period)
- You have not had a severe allergic reaction to any vaccine ingredient or to an mRNA COVID-19 vaccine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new drug called TVB-3567, which may help treat acne. It checks the drug's safety and how the body processes it, first in healthy people and then in people with moderate to severe acne.
This trial tests an mRNA vaccine designed to treat mild facial acne. It aims to see if the vaccine is safe and effective at reducing acne lesions.
This trial studies a new mRNA vaccine to see how safe it is for teenagers with moderate to severe acne. If your teen qualifies, they may receive the vaccine in either a low or high dose, while researchers monitor for side effects.
This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.
This study looks at skin swabs and blood samples from people with different levels of acne to better understand the condition. You won't receive any new treatment, but you'll help researchers learn more about acne.
This study tests a new medication called HB0043 for people with mild to moderate facial acne. It aims to see if the treatment is safe and effective in reducing acne.
Hear when a new Acne trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.